17.14

4.14% -0.74

First Tracks Biotherapeutics Inc (TRAX)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$17.88

Aprire:

$17.41

Volume 24 ore:

547.50K

Relative Volume:

1.79

Capitalizzazione di mercato:

$598.06M

Reddito:

Utile/perdita netta:

Rapporto P/E:

EPS:

Flusso di cassa netto:

1 W Prestazione:

+7.33%

1M Prestazione:

+1.42%

6M Prestazione:

+0.00%

1 anno Prestazione:

+0.00%

Intervallo 1D:

$16.78

$18.04

Intervallo di 1 settimana:

$15.73

$18.89

Portata 52W:

$14.72

$25.58

First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile

Nome

First Tracks Biotherapeutics Inc

Settore

Healthcare (1107)

Industria

Biotechnology (621)

Telefono

212-373-3000

Indirizzo

10770 WATERIDGE CIRCLE, SAN DIEGO

Dipendente

Cinguettio

Prossima data di guadagno

null

Ultimi documenti SEC

TRAX's Discussions on Twitter

Compare TRAX vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TRAX First Tracks Biotherapeutics Inc	17.14	623.88M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	453.17	114.33B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	614.73	64.47B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	878.49	54.99B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	281.90	38.42B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	156.58	34.03B	742.00K	-1.37B	-1.07B	-7.0731

First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-24	Iniziato	Leerink Partners	Outperform
2026-04-24	Iniziato	Wedbush	Outperform
2026-04-23	Iniziato	JP Morgan	Overweight
2026-04-22	Iniziato	Barclays	Overweight
2026-04-21	Iniziato	UBS	Buy

First Tracks Biotherapeutics Inc Borsa (TRAX) Ultime notizie

Jun 12, 2026

[Form 4/A] First Tracks Biotherapeutics, Inc. Amended Insider Trading Activity - Stock Titan

Jun 12, 2026

First Tracks Biotherapeutics (TRAX) director receives stock options and RSU grant - Stock Titan

Jun 12, 2026

First Tracks Biotherapeutics (TRAX) awards options and RSUs to director - Stock Titan

Jun 12, 2026

Director at First Tracks Biotherapeutics (TRAX) gets equity awards - Stock Titan

Jun 12, 2026

First Tracks Biotherapeutics (TRAX) director awarded options and RSUs - Stock Titan

Jun 12, 2026

Jun 10, 2026

H.C. Wainwright initiates AnaptysBio stock coverage with buy rating - Investing.com UK

Jun 10, 2026

H.C. Wainwright initiates AnaptysBio stock coverage with buy rating By Investing.com - Investing.com Canada

Jun 10, 2026

Jun 08, 2026

TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC

Jun 03, 2026

May 29, 2026

AnaptysBio Details Tax Treatment of Spin-Off Dividend - TipRanks

May 29, 2026

Spin-off dividend tax info posted by AnaptysBio (NASDAQ: ANAB) - Stock Titan

May 29, 2026

May 24, 2026

First Tracks Biotherapeutics (TRAX) Stock Price, News & Analysis $TRAX - MarketBeat

May 24, 2026

May 23, 2026

J.P. Morgan Maintains First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Cuts Target Price to $30 - Moomoo

May 23, 2026

May 22, 2026

First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - Sahm

May 22, 2026

May 21, 2026

Zumiez Inc. to Report Fiscal 2026 First Quarter Results - The Manila Times

May 21, 2026

First Tracks Biotherapeutics (TRAX) Stock Forecast and Price Target 2026 $TRAX - MarketBeat

May 21, 2026

Autoimmune drug biotech First Tracks to meet investors at Jefferies, Leerink - Stock Titan

May 21, 2026

May 20, 2026

TRAXV SEC FilingsFirst Tracks Biotherapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

May 20, 2026

May 18, 2026

First Tracks Biotherapeutics, Inc.Ordinary Shares (NQ: TRAX - FinancialContent

May 18, 2026

May 17, 2026

AnaptysBio (ANAB) Valuation After Spin Off And Shift To Royalty Focused Model - Sahm

May 17, 2026

May 15, 2026

First Tracks Biotherapeutics (NASDAQ: TRAX) registers 10.5M resale shares; issuer gets no proceeds - Stock Titan

May 15, 2026

Emily Bodnar Reiterates Buy on AnaptysBio, Keeps $30 Price Target on ANB033 Progress and Solid Cash Runway - TipRanks

May 15, 2026

TRAX SEC FilingsFirst Tracks Biotherapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 15, 2026

How The Grupo Traxión (BMV:TRAXION A) Story Is Shifting With Cautious New Analyst Targets - Yahoo Finance

May 15, 2026

May 14, 2026

Form 424B3 First Tracks Biotherapeu - StreetInsider

May 14, 2026

First Tracks Biotherapeutics (NASDAQ: TRAX) registers 10.5M resale shares - Stock Titan

May 14, 2026

First Tracks Biotherapeutics 1Q 2026: Net loss $(50.5M), Revenue $0— 10-Q Summary - TradingView

May 14, 2026

[Form 4] First Tracks Biotherapeutics, Inc. Insider Trading Activity - Stock Titan

May 14, 2026

First Tracks Biotherapeutics (NASDAQ: TRAX) details Q1 loss and major post spin-off cash raises - Stock Titan

May 14, 2026

First Tracks Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 14, 2026

First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update - The Manila Times

May 14, 2026

[8-K] First Tracks Biotherapeutics, Inc. Reports Material Event - Stock Titan

May 14, 2026

Director at First Tracks Bio (NASDAQ: TRAX) receives new equity awards - Stock Titan

May 14, 2026

Director Magda Marquet granted options and RSUs at First Tracks (TRAX) - Stock Titan

May 14, 2026

Director at First Tracks Biotherapeutics (TRAX) granted options and RSUs - Stock Titan

May 14, 2026

Director John A. Orwin receives new equity awards at First Tracks Biotherapeutics (TRAX) - Stock Titan

May 14, 2026

First Tracks (TRAX) awards director 42,000 options and 15,000 RSUs - Stock Titan

May 14, 2026

Executive equity awards at First Tracks Biotherapeutics (TRAX) detailed - Stock Titan

May 14, 2026

First Tracks (TRAX) CEO receives new stock options and RSU awards - Stock Titan

May 14, 2026

First Tracks Biotherapeutics (TRAX) CFO receives new option and RSU awards - Stock Titan

May 14, 2026

May 13, 2026